6X7I
Structure of the C-terminal domain of BCL-XL in membrane
Summary for 6X7I
| Entry DOI | 10.2210/pdb6x7i/pdb |
| NMR Information | BMRB: 30757 |
| Descriptor | Bcl-2-like protein 1 (1 entity in total) |
| Functional Keywords | anti-apoptotic, bcl-2, membrane, membrane protein |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 1 |
| Total formula weight | 3174.72 |
| Authors | Yao, Y.,Tian, Y.,Marassi, F.M. (deposition date: 2020-05-30, release date: 2020-07-01, Last modification date: 2024-05-15) |
| Primary citation | Ryzhov, P.,Tian, Y.,Yao, Y.,Bobkov, A.A.,Im, W.,Marassi, F.M. Conformational States of the Cytoprotective Protein Bcl-xL. Biophys.J., 119:1324-1334, 2020 Cited by PubMed Abstract: Bcl-xL is a major inhibitor of apoptosis, a fundamental homeostatic process of programmed cell death that is highly conserved across evolution. Because it plays prominent roles in cancer, Bcl-xL is a major target for anticancer therapy and for studies aimed at understanding its structure and activity. Although Bcl-xL is active primarily at intracellular membranes, most studies have focused on soluble forms of the protein lacking both the membrane-anchoring C-terminal tail and the intrinsically disordered loop, and this has resulted in a fragmented view of the protein's biological activity. Here, we describe the conformation of full-length Bcl-xL. Using NMR spectroscopy, molecular dynamics simulations, and isothermal titration calorimetry, we show how the three structural elements affect the protein's structure, dynamics, and ligand-binding activity in both its soluble and membrane-anchored states. The combined data provide information about the molecular basis for the protein's functionality and a view of its complex molecular mechanisms. PubMed: 32888404DOI: 10.1016/j.bpj.2020.08.014 PDB entries with the same primary citation |
| Experimental method | SOLID-STATE NMR SOLUTION NMR |
Structure validation
Download full validation report






